These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35396795)

  • 1. A full-scale tracing study of "ghost peaks" encountered in impurity analysis of budesonide based on experimental operation inspection-liquid chromatography/mass spectrometry fingerprint-mechanism based stress studies integrated strategy.
    Zhang L; Hu Q; Wang J; Zhang H; Han J
    J Sep Sci; 2022 Jul; 45(13):2128-2139. PubMed ID: 35396795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy].
    Chen ZZ; Zhang DS; Wang N; Feng F; Hu CQ
    Yao Xue Xue Bao; 2012 Apr; 47(4):492-7. PubMed ID: 22799032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of ghost peaks by optimization of anion exchange chromatography method for determination of gamma-carboxyglutamic acid (Gla)-domainless impurity in recombinant activated clotting factor VII drug products.
    Tahmasbi H; Zarezadeh N; Marjaninia S; Molavi B; Maleknia S; Mahboudi F; Behrouz H
    J Pharm Biomed Anal; 2019 Jul; 171():1-7. PubMed ID: 30953797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stability-indicating HPLC assay method for budesonide.
    Hou S; Hindle M; Byron PR
    J Pharm Biomed Anal; 2001 Jan; 24(3):371-80. PubMed ID: 11199216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of unknown impurities in Coenzyme Q
    Deng Y; Chen X; Wang L; Peng X; Lin M
    J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using thermal forced degradation approach for impurity profiling of budesonide solution-formulated metered dose inhalation with implementation of LC-QTOFMS and HPLC-UV.
    Peng M; Song D; Ling X; Jiang W; Zhang Y; Yang Y; Le J
    J Pharm Biomed Anal; 2022 Jan; 208():114445. PubMed ID: 34763210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic studies of unusual on-column degradation of cefaclor observed in the impurity separation by HPLC.
    Zhong JS; Huang Y; Wan JZ; Yu XY; Yu AL; Zeng HX; Chen ZY; Zhou XR; Ding M
    J Pharm Biomed Anal; 2019 Nov; 176():112818. PubMed ID: 31446297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinquennial Review of Progress in Degradation Studies and Impurity Profiling: An Instrumental Perspective Statistics.
    Shelke M; Deshpande SS; Sharma S
    Crit Rev Anal Chem; 2020; 50(3):226-253. PubMed ID: 31111727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR.
    Awasthi A; Razzak M; Al-Kassas R; Greenwood DR; Harvey J; Garg S
    Anal Bioanal Chem; 2012 Nov; 404(8):2203-22. PubMed ID: 22986987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Ghost peaks" of ezetimibe: Solution degradation products of ezetimibe in acetonitrile induced by alkaline impurities from glass HPLC vials.
    Jin J; Wang Z; Lin J; Zhu W; Gu C; Li M
    J Pharm Biomed Anal; 2017 Jun; 140():281-286. PubMed ID: 28376385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an analytical method for the determination of pimavanserin and its impurities applying analytical quality by design principles as a risk-based strategy.
    Radić I; Runje M; Babić S
    J Pharm Biomed Anal; 2021 Jul; 201():114091. PubMed ID: 33964725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validated assay for the simultaneous determination of cortisol and budesonide in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry.
    Szeitz A; Manji J; Riggs KW; Thamboo A; Javer AR
    J Pharm Biomed Anal; 2014 Mar; 90():198-206. PubMed ID: 24389462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of sub-2-microm particle liquid chromatography-operated high mobile linear velocities coupled to orthogonal accelerated time-of-flight mass spectrometry for the analysis of ranitidine and its impurities.
    Jones MD; Plumb RS
    J Sep Sci; 2006 Nov; 29(16):2409-20. PubMed ID: 17154121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of hyphenated LC-MS technique for characterisation of impurity profiles during drug development.
    Ermer J
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):707-14. PubMed ID: 9919972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Ghost peak" of clofazimine: A solution degradation product of clofazimine via nucleophilic substitution by nitrite leaching from certain glass HPLC vials.
    Lin J; Lin Z; Li D; Feng M; Yang Q; Hu W; Han Y; Zhu W; Li M; Yu L
    J Pharm Biomed Anal; 2018 Feb; 150():183-190. PubMed ID: 29245088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.